0M0F.LSE Tandem Diabetes Care, Inc.
- Market cap
- -
- P/E
- 211.9x
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is 0M0F.LSE undervalued?
Graham numberThe Graham number of Tandem Diabetes Care, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Tandem Diabetes Care, Inc. fundamental analysis
No fundamental analysis for Tandem Diabetes Care, Inc. yet.
Tandem Diabetes Care, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it …
Full company profileFinancial statements of Tandem Diabetes Care, Inc. are not available yet.
Tandem Diabetes Care, Inc. dividends
Tandem Diabetes Care, Inc. has not paid dividends in the last 4 fiscal years.
Who owns Tandem Diabetes Care, Inc.
- Insiders 1.17%
- Institutions 98.83%
- Public & others 0.00%
- Free float 63.8M
Tandem Diabetes Care, Inc. company profile
- Company name
- Tandem Diabetes Care, Inc.
- Ticker
- 0M0F.LSE
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 2,500
- Fiscal year end
- December
- Address
- 12400 High Bluff Drive, San Diego, CA, United States, 92130
- Phone
- 858 366 6900
- Website
- tandemdiabetes.com
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Tandem Diabetes Care, Inc. management
9- Mr. John F. SheridanPresident, CEO & Director · born 1955
- Ms. Leigh A. VossellerExecutive VP, CFO & Treasurer · born 1973
- Ms. Shannon M. Hansen J.D.Executive VP, Chief Legal, Privacy & Compliance Officer and Secretary · born 1966
- Ms. Elizabeth Anne GasserExecutive VP and Chief Strategy & Product Officer · born 1976
- Mr. Jean-Claude E. KyrillosExecutive VP & COO · born 1964
- Mr. Rick A. CarpenterExecutive VP & CTO · born 1963
- Ms. Susan M. MorrisonExecutive VP & Chief Administrative Officer · born 1979
- Mr. Tom FoxExecutive VP & Chief Human Resources Officer
- Dr. Jordan Pinsker M.D.Chief Medical Officer